Zinc intake has positive impact on bones

July 12, 2021

Zinc, a nutritional trace element, is essential for the growth of human and animals.1 Zinc is required for the growth, development, and maintenance of healthy bones. Bone growth retardation is a common finding in various conditions associated with zinc deficiency.2 In Iranian schoolboys at year 1961, zinc supplementation was first found to restore both skeletal growth and maturation.3 Zinc deficiency is associated with many kinds of skeletal abnormalities in fetal and postnatal development. Zinc may play a physiologically important role in bone homeostasis. Skeleton contains a large proportion of the total body burden of zinc.4 Bone zinc has been shown to be concentrated in the layer of osteoid prior to calcification.5 

 

Osteoporotic patients have been shown to have lower levels of skeletal zinc than healthy individuals.6 The reduction levels of biological markers of nutrition in postmenopausal osteoporosis may be related to zinc deficiency. In postmenopausal women, urinary zinc has been used as a marker of bone resorption. Plasma and urinary zinc concentrations in 30 women with postmenopausal osteoporosis and in 30 healthy postmenopausal women who served as controls have been measured.7 Plasma zinc levels did not differ between groups, but urinary zinc excretion has been found to be significantly higher in the women with postmenopausal osteoporosis.The elevation of urinary zinc elimination in osteoporosis may be dependent on bone resorption8 because zinc is located richly in bone tissues. To examine the independent association between dietary zinc and plasma zinc and the association of each with bone mineral density (BMD) and 4-year bone loss in community-dwelling older men. Of the original Rancho Bernardo Study subjects, 396 men (age: 45–92 years) were used. The mean dietary zinc intake was 11.2 mg. Dietary zinc intake and plasma zinc each have a positive association with BMD in men.8

 

Feel free to reach us for queries admin(at)youngatbones.com

Connect with us on:

facebook – twitter – LinkedIn – Instagram

 

References

  1. Prasad AS, Halsted JA, Nadimi M (1961) Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Am J Med 31:532–546.
  2. Hsieh HS, Navia JM (1980) Zinc deficiency and bone formation in guinea pig alveolar implants. J Nutr 110:1581–1588.
  3. Ronaghy HA, Reinhold JG, Mahloudji M, Ghavami P, Spirey Fox MR, Halstead JA (1984) Zinc supplementation of malnourished schoolboys in Iran: increased growth and other effects. Am J Clin Nutr 40:1203–1212.
  4. Herzberg M, Foldes J, Steinberg R, Menczel J (1990) Zinc excretion in osteoporotic women. J Bone Miner Res 5:251–257.
  5. Hurley LS, Shyy-Hwa T (1972) Alleviation of tetratogenic effects of zinc deficiency by simultaneous lack of calcium. Am J Phys 222:322–325.
  6. Reginster JY, Strause LG, Saltman O, Franchimont P (1988) Trace elements and postmenopausal osteoporosis: a preliminary study of decreased serum manganese. Med Sci Res 16:337– 338.
  7. Relea P, Revilla M, Ripoll E, Arribas I, Villa LF, Rico H (1995) Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 24:303–307.
  8. Hyun TH, Barrett-Connor E, Milne DB (2004) Zinc intakes and plasma concentrations in men with osteoporosis: the Rancho Bermardo Study. Am J Clin Nutr 80:715–721.

 

Disclaimer: This material is for informational purpose only. It does not replace the advice or counsel of a doctor or health care professional.  You should consult with, and rely only on the advice of, your physician or health care professional.
Contacts
  • Head Office: DEVASHISH BUILDING, ALKEM HOUSE, SENAPATI BAPAT ROAD, LOWER PAREL, MUMBAI - 400 013
  • Phone: +91 22 3982 99 99
  • Phone: 1800 212 0767
  • Email: contact@alkem.com